CCND1 and triple-negative breast carcinoma: This report describes, for the first time, a functional role for miR-1296 in triple negative breast cancer, identifies CCND1 as a target of miR-1296 action, and demonstrates the potential for miR-1296 to sensitize TNBC cells to chemotherapeutic agents.